Praliciguat
CAS: 1628730-49-3
Ref. 3D-BP177758
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Product Information
Praliciguat is a drug that has the potential to be used in the treatment of chronic pulmonary diseases. It is a soluble guanylate cyclase (sGC) stimulator, which can promote the release of nitric oxide from endothelial cells. Praliciguat also increases insulin sensitivity and improves cardiac function in patients with chronic heart failure. This drug has been shown to have beneficial effects on hepatic steatosis and insulin resistance in experimental animals. Praliciguat has also been shown to improve insulin sensitivity, reduce inflammation, and inhibit viral replication in animal models of type 1 diabetes.
Chemical properties
Technical inquiry about: 3D-BP177758 Praliciguat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
